1. Stocks
  2. Sun Pharmaceutical Industries Ltd.
  3. Swot
swot-logo

Sun Pharmaceutical Industries Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Sun Pharmaceutical Industries Ltd. has 12 Strengths, 13 Weaknesses, 7 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Consistent Highest Return Stocks over Five Years

Stocks with Consistent Share Price Growth (subscription)

Expensive Performers (DVM)

PEG lower than Industry PEG

Dividend yield greater than sector dividend yield

Effectively using its capital to generate profit - RoCE improving in last 2 years

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Volume Shockers

Promoters increased pledged shares QoQ

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining profits every quarter for the past 2 quarters

Declining Net Cash Flow : Companies not able to generate net cash

Weak Momentum: Price below Short, Medium and Long Term Averages

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Increasing Trend in Non-Core Income

RSI indicating price weakness

High promoter stock pledges

Highest increase in pledges by promoters

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Broker price or reco upgrades in last month

Brokers upgraded recommendation or target price in the past three months

Mutual Funds Increased Shareholding in Past Month

Street Favorite: High Analyst Rating with at least 20% upside

Broker Upgrades: Stocks where brokers upgraded recommendation or price target in the past one month

FII / FPI or Institutions increasing their shareholding

Broker price or reco upgrades in last month

Red Flags: Firms linked to ongoing regulatory investigations/legal cases

Broker downgrades in price or recommendation in the past one month

MFs decreased their shareholding last quarter

High Piotroski Score - Companies with strong financials

Rising Delivery Percentage Compared to Prev Day

Expensive Performers (DVM)

Decline in Net Profit with falling Profit Margin (QoQ)